Today is Clinical Trials Day and we're highlighting some of the exciting trials people with progressive MS can join in the UK right now.

PhD student Imogen Collier and two people with MS tell us about a project to improve understanding of menopause and MS.

Researchers An, Valeria and Simon are thousands of miles apart. But they all share the same goal: to solve the mystery of what causes MS progression.

Dr Emma Gray, our Assistant Director of Research, and Sasha Leigh, who lives with MS, reflect on what research has achieved in recent years.

Lauren Taylor, a Clinical Psychology PhD student, told us about the NEuRoMS project. It aims to change how cognitive MS symptoms are managed.

The ADAMS study is investigating how genes affect the risk of getting MS in people from different ethnic backgrounds. Three people involved told us why the study is so important.

We asked a few people with MS what motivated them to take part in some of our research studies and what their experience was like.

A new immunotherapy treatment in a trial for progressive MS hit the headlines recently. News reports say it could reverse or stabilise the progression of MS by targeting the Epstein-Barr virus (EBV). We looked behind the headlines to find out more.

MRI technology has been evolving. Techniques are faster and more powerful than ever. And researchers are making the most of this new technology so we can stop MS sooner. Find out how we've been using it in our trials.

Hannah is a Research Communications Officer. She tells us the ins and outs of research communications at the MS Society and why it’s such a rewarding job.